Cargando…
A butanolic fraction from the standardized stem extract of Cassia occidentalis L delivered by a self-emulsifying drug delivery system protects rats from glucocorticoid-induced osteopenia and muscle atrophy
We recently reported that a butanol soluble fraction from the stem of Cassia occidentalis (CSE-Bu) consisting of osteogenic compounds mitigated methylprednisone (MP)-induced osteopenia in rats, albeit failed to afford complete protection thus leaving a substantial scope for further improvement. To t...
Autores principales: | Pal, Subhashis, Mittapelly, Naresh, Husain, Athar, Kushwaha, Sapana, Chattopadhyay, Sourav, Kumar, Padam, Ramakrishna, Eppalapally, Kumar, Sudhir, Maurya, Rakesh, Sanyal, Sabyasachi, Gayen, Jiaur R., Mishra, Prabhat R., Chattopadhyay, Naibedya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957531/ https://www.ncbi.nlm.nih.gov/pubmed/31932603 http://dx.doi.org/10.1038/s41598-019-56853-6 |
Ejemplares similares
-
Simultaneous quantification of five biomarkers in ethanolic extract of Cassia occidentalis Linn. stem using liquid chromatography tandem mass spectrometry: application to its pharmacokinetic studies
por: Riyazuddin, Mohammed, et al.
Publicado: (2020) -
Correction: Simultaneous quantification of five biomarkers in ethanolic extract of Cassia occidentalis Linn. stem using liquid chromatography tandem mass spectrometry: application to its pharmacokinetic studies
por: Riyazuddin, Mohammed, et al.
Publicado: (2021) -
Poisoning by Cassia Occidentalis
por: Kundu, M. L.
Publicado: (1912) -
Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:2609–2623
por: Khan, Mohd. Parvez, et al.
Publicado: (2017) -
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells
por: Kumar, Harish, et al.
Publicado: (2020)